Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd.
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is...
advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 11, 2022 7:10am
Revive Therapeutics Webcast - February 10, 2022
#Bucillamine https://www.reddit.com/r/RVVTF/comments/sptzcm/revive_therapeutics_webcast_february_10_2022/?utm_source=share&utm_medium=web2x&context=3
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 11, 2022 6:59am
Pandemic has not ended as more variants expected
#Bucillamine https://www.ekathimerini.com/news/1177325/who-chief-scientist-pandemic-has-not-ended-as-more-variants-expected/
GameSquare Announces Formation of FaZe Media, a Creator-led IP and Media Company, led by CEO FaZe Banks and Backed by $11 Million Investment from Matt Kalish
posted May 16, 2024 9:00am by
GameSquare Holdings Inc.
-
|
Justin Kenna, CEO of GameSquare stated, "Since completing the acquisition of FaZe Clan, we have focused on returning FaZe's founders to reboot their brand and reestablish its authenticity. We are thrilled to better capitalize this business for growth with $11 million in new capital from Matt, and to strengthen the FaZe Media board with his addition. Matt deeply believes in the power of founder and creator-led organizations and ...read more
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Feb 10, 2022 8:40pm
RE:RE:RE:A realistic scenario
I'm all over the place! The SP here will be down 10% before the end of the month. It hits my .24 target, maybe lower! On the bright side, still some time for those savvy enough to ball up
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Comment by
cool888
on Feb 10, 2022 8:18pm
RE:RE:A realistic scenario
Dude - Just SHUT UP or leave this BB .... Mister know everything ... Fuc*kin* day trader, find something else ..
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Feb 10, 2022 11:53am
RE:A realistic scenario
Actually a very good article. It's just too bad the management here is what it is. This trial could have ended 6 months ago if MF had offered the proper stipend for trial recruitment. He was
...more
(18)
•••
Hydroqc
X
View Profile
View Bullboard History
Post by
Hydroqc
on Feb 10, 2022 11:22am
A realistic scenario
https://www.pharmacytimes.com/view/the-fight-to-treat-covid-19-sorting-through-therapeutics-from-antivirals-to-anti-inflammatories?fbclid=IwAR1mjr4ZDfVsBaB8XiOu7KxBqU21xN-SwQv7nqEvYLHLFqFiJgqq5oS6naY
...more
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Post by
1ottrunner
on Feb 10, 2022 10:25am
Update from the company: what does it mean?
RVV has updated the trial to say they expect completion end of Q1. That means that NOTHING is happening here for no less than 45 days. Let's inlcude data colelction and analysis: 90 days! I'
...more
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Comment by
TheTerminator1
on Feb 10, 2022 10:06am
RE:RE:RE:$RVV - ClinicalTrials - Updated !!
Doing your thing again this morning!!!
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Feb 10, 2022 9:46am
RE:RE:$RVV - ClinicalTrials - Updated !!
Everyone should take note that the Turkish site is NOT included in the trial update and the data WILL NOT be included also. The trial will not end March 31, the SP will be below 20 cents.
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Feb 10, 2022 9:35am
RE:$RVV - ClinicalTrials - Updated !!
Its a stupid update. primary and completion are the same. if an update needs to be done, it shld be done properly.
(870)
•••
CrazyProphet
X
View Profile
View Bullboard History
Comment by
CrazyProphet
on Feb 10, 2022 9:22am
RE:$RVV - ClinicalTrials - Updated !!
They could have picked any random date other than the 31st IMO ? Pick a date the 15th the 21st anything but end of month date ! That EOM date just adds and 50 plus days IMO psychology works against
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 10, 2022 9:05am
$RVV - ClinicalTrials - Updated !!
#Bucillamine https://clinicaltrials.gov/ct2/history/NCT04504734?A=34&B=35&C=merged#StudyPageTop
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Feb 10, 2022 8:35am
RE:Interesting read .. Sionogi's Antiviral Covid Pill
The comments on this reddit thread are moronic. First, Japan has had access to Bucillamine for arthritis for 30 years.So the data exists, if you are taking Buc for that indication have you not been
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 10, 2022 8:26am
Interesting read .. Sionogi's Antiviral Covid Pill
#Bucillamine https://www.reddit.com/r/RVVTF/comments/sn9x71/sionogis_antiviral_covid_pill/
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
IAMGOLD Reports First Quarter 2024 Results
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment